Health

Results: 6613-6624 of 8104

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Desert Control releases its Q4 2023 Report and Year-to-date Company Update

ICON Reports Fourth Quarter and Full Year 2023 Results

Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance

LetsGetChecked Launches myGeneticScreen, a Genetic Testing Service Designed to Deliver Personalized, Actionable Insights into Predisposition for Inherited Cancers and Cardiovascular Diseases

PR Newswire associated0

Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer

MMI Raises $110 Million in Series C Financing

PR Newswire associated0

Clario Achieves ISO 27001 Certification, Demonstrating Commitment to Information Security

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

Volpara to Highlight Growing AI Suite for Mammography at ECR 2024, Including New Lunit Distribution Agreement

Aleta Biotherapeutics and Cancer Research UK’s Centre for Drug Development Announce First Patient Dosed in ALETA-001 Phase 1/2 Clinical Trial in Patients with Relapsed/Refractory B-Cell Malignancies

Invitation to presentation of Sectra's nine-month interim report 2023/2024